Item 8.01. Other Events.

On December 21, 2022, Venus Concept Inc. (the "Company") issued a press release relating to its receipt of 510(k) clearance from the U.S. Food and Drug Administration (the "FDA") to market AI.ME, the Company's next generation robotic technology, for fractional skin resurfacing. A copy of the press release regarding the above-described FDA clearance is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.





Exhibit
  No.      Description

  99.1     Press release dated December 21, 2022.
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses